Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis
- PMID: 26215715
- DOI: 10.1111/bjd.14053
Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis
Abstract
Evaluation of human data regarding the outcomes of topical-retinoid-exposed pregnancies is important in terms of counselling pregnant women with inadvertent exposure. The objective of this study was thus to determine whether exposure to topical retinoids leads to an increase in the risk of adverse pregnancy outcomes. We carried out a search using the Medline, Embase, Web of Science and Cochrane Central Register of Controlled Trials databases from inception to 4 December 2014. The selection, review and quality assessment of the studies were carried out by two independent reviewers according to predetermined inclusion criteria. Odds ratios (ORs) were calculated by the random effects method. This meta-analysis, including a total of 654 pregnant women who were exposed to topical retinoids, and 1375 unexposed control pregnant women, did not detect significant increases in rates of major congenital malformations [OR 1·22, 95% confidence interval (CI) 0·65-2·29], spontaneous abortions (OR 1·02, 95% CI 0·64-1·63), stillbirth (OR 2·06, 95% CI 0·43-9·86), elective termination of pregnancy (OR 1·89, 95% CI 0·52-6·80), low birthweight (OR 1·01, 95% CI, 0·31-3·27) or prematurity (OR 0·69, 95% CI 0·39-1·23). No significant heterogeneity was detected among the studies for the evaluated outcomes. The present meta-analysis ruled out a major increase in the rates of major congenital malformations, spontaneous abortions, low birthweight and prematurity. This result may be used primarily in reassuring women who were inadvertently exposed to topical retinoids during their pregnancy. However, the statistical power is not adequate to justify the use of topical retinoids during pregnancy.
© 2015 British Association of Dermatologists.
Comment in
-
What is the risk of inadvertent exposure to topical retinoids during first trimester pregnancy?Br J Dermatol. 2015 Nov;173(5):1117-8. doi: 10.1111/bjd.14191. Br J Dermatol. 2015. PMID: 26769634 No abstract available.
Similar articles
-
Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.Ann Rheum Dis. 2018 Apr;77(4):500-509. doi: 10.1136/annrheumdis-2017-212078. Epub 2017 Dec 8. Ann Rheum Dis. 2018. PMID: 29222350
-
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.Br J Clin Pharmacol. 2016 May;81(5):835-48. doi: 10.1111/bcp.12872. Epub 2016 Feb 16. Br J Clin Pharmacol. 2016. PMID: 26700396 Free PMC article. Review.
-
Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study.JAMA Dermatol. 2013 Nov;149(11):1274-80. doi: 10.1001/jamadermatol.2013.5768. JAMA Dermatol. 2013. PMID: 24005903
-
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.J Clin Pharmacol. 2012 Dec;52(12):1844-51. doi: 10.1177/0091270011429566. Epub 2011 Dec 15. J Clin Pharmacol. 2012. PMID: 22174426
-
Safety of topical corticosteroids in pregnancy.Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007346. doi: 10.1002/14651858.CD007346.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Oct 26;(10):CD007346. doi: 10.1002/14651858.CD007346.pub3. PMID: 19588425 Updated. Review.
Cited by
-
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review.Dermatol Ther (Heidelb). 2024 May;14(5):1079-1091. doi: 10.1007/s13555-024-01169-1. Epub 2024 May 3. Dermatol Ther (Heidelb). 2024. PMID: 38700645 Free PMC article. Review.
-
Management of Acne in Pregnancy.Am J Clin Dermatol. 2024 May;25(3):465-471. doi: 10.1007/s40257-024-00851-6. Epub 2024 Mar 7. Am J Clin Dermatol. 2024. PMID: 38453786 Review.
-
Risk factors for preterm birth: an umbrella review of meta-analyses of observational studies.BMC Med. 2023 Dec 13;21(1):494. doi: 10.1186/s12916-023-03171-4. BMC Med. 2023. PMID: 38093369 Free PMC article. Review.
-
Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations.Adv Ther. 2022 Dec;39(12):5351-5375. doi: 10.1007/s12325-022-02319-7. Epub 2022 Oct 11. Adv Ther. 2022. PMID: 36220974 Free PMC article. Review.
-
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.Pediatr Dermatol. 2021 Jan;38(1):164-180. doi: 10.1111/pde.14408. Epub 2020 Nov 10. Pediatr Dermatol. 2021. PMID: 33169909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical